Skip to content

A multicentre randomized controlled trial of transcutaneous auricular vagus nerve stimulation to improve fatigue and quality of life after radiotherapy in patients with thoracic tumors

A multicentre randomized controlled trial of transcutaneous auricular vagus nerve stimulation to improve fatigue and quality of life after radiotherapy in patients with thoracic tumors

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072800
Enrollment
Unknown
Registered
2023-06-26
Start date
2023-06-26
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

experimental group:cancer related fatigue standard treatment and transcutaneous auricular vagus nerve stimulation
control group:cancer related fatigue standard treatment and sham transcutaneous auricular vagus nerve stimulation

Sponsors

The First Affiliated Hospital of the Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Patients with adjuvant radiotherapy after breast cancer surgery or patients with radical radiotherapy and chemotherapy for esophageal cancer 2) Age= 18 years old 3) ECOG score 0-2 points

Exclusion criteria

Exclusion criteria: 1) Patients with brain organic lesions, peptic ulcers, arrhythmias, cardiac QTc interval > 450ms, bradypnea (respiratory rate less than 10 times per minute) and other patients who are not suitable for vagus nerve stimulation treatment; 2) Those who use anticholinergic and anti-insomnia drugs; 3) Patients with moderate to severe anemia; 4) Patients with thyroid dysfunction; 5) Patients with major depressive disorder and other mental disorders who are currently or have been diagnosed; 6) Those who are participating in or have participated in vagus nerve or transcranial electrical stimulation therapy for less than 3 months; 7) Those who refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
The proportion of patients with fatigue scores(BFI) improved or worsened by more than 2 points;

Secondary

MeasureTime frame
Physical, emotional, and cognitive dimensions fatigue scores;Anxiety and depression scores;Quality of life scores;Sleep quality score;Inflammatory factors;Lymphopenia;

Countries

China

Contacts

Public ContactZhao Li'na

The First Affiliated Hospital of the Air Force Medical University (Xijing Hospital)

zhaolinazln@outlook.com+86 135 7255 3455

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026